Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence

Stopped The recruitment of participants was no longer sufficient to continue the study.

Conditions

• Crohn Disease

Interventions

• OTHER: Immunomonitoring-based follow-up
• OTHER: Standard follow-up

Sponsor

University Hospital, Montpellier